Best TWAS P=3.68e-11 · Best GWAS P=5.19e-09 conditioned to 0.278
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | FAM160A1 | 0.04 | 0.04 | blup | 436 | 0.06 | 1.8e-07 | -3.0 | 5.2 | 2.2e-07 | -0.63 | 0.84 | 0.15 | FALSE |
2 | GTEx | Brain Cerebellar Hemisphere | SH3D19 | 0.28 | 0.22 | lasso | 5 | 0.20 | 9.3e-06 | 5.6 | -5.5 | 4.5e-08 | 0.80 | 0.04 | 0.94 | FALSE |
3 | GTEx | Brain Cerebellar Hemisphere | RP11-164P12.4 | 0.47 | 0.44 | enet | 18 | 0.35 | 6.6e-10 | 5.5 | 5.5 | 2.9e-08 | -0.81 | 0.05 | 0.95 | FALSE |
4 | GTEx | Colon Sigmoid | PET112 | 0.13 | 0.08 | enet | 18 | 0.03 | 2.6e-02 | -3.5 | 5.5 | 4.4e-08 | -0.69 | 0.18 | 0.60 | FALSE |
5 | GTEx | Spleen | RP11-164P12.4 | 0.36 | 0.26 | lasso | 10 | 0.20 | 5.8e-06 | 5.6 | 5.6 | 2.1e-08 | -0.82 | 0.04 | 0.94 | FALSE |
6 | NTR | Blood | FAM160A1 | 0.03 | 0.02 | enet | 26 | 0.02 | 1.4e-07 | -5.8 | 6.6 | 3.7e-11 | -0.94 | 0.02 | 0.98 | TRUE |
7 | The Cancer Genome Atlas | Breast Invasive Carcinoma | FAM160A1 | 0.04 | 0.02 | blup | 99 | 0.02 | 1.2e-05 | 5.6 | 5.9 | 4.3e-09 | -0.91 | 0.03 | 0.96 | FALSE |
8 | The Cancer Genome Atlas | Colon Adenocarcinoma | FAM160A1 | 0.06 | 0.05 | lasso | 3 | 0.04 | 1.8e-03 | -5.8 | 5.5 | 3.3e-08 | -0.97 | 0.03 | 0.83 | FALSE |
9 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | FAM160A1 | 0.08 | 0.05 | blup | 99 | 0.05 | 2.9e-03 | -4.1 | 5.3 | 1.2e-07 | -0.90 | 0.04 | 0.69 | FALSE |
10 | The Cancer Genome Atlas | Prostate Adenocarcinoma | FAM160A1 | 0.09 | 0.10 | lasso | 2 | 0.10 | 3.3e-10 | 5.3 | 5.4 | 8.2e-08 | -0.76 | 0.06 | 0.94 | FALSE |
11 | The Cancer Genome Atlas | Uterine Corpus Endometrial Carcinoma | FAM160A1 | 0.16 | 0.14 | enet | 33 | 0.11 | 6.6e-04 | 5.5 | 5.3 | 9.9e-08 | -0.83 | 0.05 | 0.93 | FALSE |